Shaw Science Partners, Inc. – Trademark Portfolio
Entity Type: 03
Shaw Science Partners, Inc. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 10 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 2 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include SCIENCE STORY, SCIENCE AGENCY, STRATEGIC SCIENCE, VISUAL NOMENCLATURE, and SHAW SCIENCE PARTNERS. The owner is based in Atlanta, GA.
4151 Ashford Dunwoody Rd. Suite 650
Atlanta, GA 30319
Showing of trademarks Trademarks
Trademark Classifications
Shaw Science Partners, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Shaw Science Partners, Inc. have?
Shaw Science Partners, Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 7 registered, 3 abandoned.
What trademark classes does Shaw Science Partners, Inc. file in?
Shaw Science Partners, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 40 (Treatment & Processing). Class 35 covers advertising; business management; business administration; office functions.
What are Shaw Science Partners, Inc.'s most well-known trademarks?
Shaw Science Partners, Inc.'s registered trademark portfolio includes well-known marks such as SCIENCE STORY, SCIENCE AGENCY, STRATEGIC SCIENCE, VISUAL NOMENCLATURE, and SHAW SCIENCE PARTNERS. These are among 7 currently registered trademarks in the portfolio.
What is Shaw Science Partners, Inc.'s trademark registration success rate?
Shaw Science Partners, Inc. has a 70% trademark registration rate, with 7 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.